Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Accuracy and Reproducibility of ChatGPT Responses to Breast Cancer Tumor Board Patients.
Journal: JCO clinical cancer informatics
Published: June 04, 2025
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study.
Journal: Breast cancer research and treatment
Published: May 10, 2025
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026).
Journal: Breast (Edinburgh, Scotland)
Published: November 04, 2024
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.
Journal: Nature communications
Published: July 04, 2024
Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 12, 2023
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.
Journal: Nature communications
Published: April 08, 2021
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: September 05, 2019
Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancer.
Journal: Psycho-oncology
Published: October 23, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026